Latest Blogs

Jul 27, 2021
Dr. Nizar Bitar and I review the 2021 Best of ASCO Lebanon meeting, which featured an extraordinary faculty from all over the globe and our talented colleagues here in Lebanon.
Jul 27, 2021
July is a time of new beginnings and transitions in academic medicine. As I wrapped up my fellowship, I thought often of the adage: “Comparison is the thief of joy.”
Jul 22, 2021
Dr. Jennifer Temel and Dr. Daniel E. Lage discuss building a career in cancer symptom management research.
Jul 21, 2021
Dr. Samer Al Hadidi shares how a clear strategy may help to choose the best conference/s to attend according to interest and/or availability. 
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the medical director for the Cancer Care Partnership with Penn State University Cancer Institute and professor of medicine at Penn State Hershey Cancer Institute. He has served as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is past president of the Pennsylvania Society of Oncology and Hematology. He serves as an ASCO delegate to the American Medical Association House of Delegates (AMA HOD).

Disclosure.

Jun 30, 2021
ASCO’s delegation to the American Medical Association (AMA) recently met virtually with the AMA’s House of Delegates (HOD), with a focus on payment reform models. 
Dec 02, 2020
Despite the virtual nature of the AMA House of Delegates meeting, the decisions made there have a very real impact on our profession and the patients we serve.
Jun 10, 2020
Although our societal meetings, including the AMA House of Delegates meeting, are shortened, they have never been more important than they are at this moment.
Dec 03, 2019
ASCO's delegation to the AMA HOD invites all ASCO members to share their thoughts and concerns concerning issues affecting the practice of oncology, as your input directly impacts the delegation's work.
Jun 20, 2019
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
Nov 19, 2018
At a recent meeting, the ASCO delegation to the AMA House of Delegates presented concerns focused on the Competitive Acquisition Program (CAP), among a variety of other issues.

Pages